...
search icon
aton-img

AlphaTON Capital Corp., Common Stock

ATON

NAQ

$5.39

-$0.14

(-2.53%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$33.32M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
295.57K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.95 L
$15.82 H
$5.39

About AlphaTON Capital Corp., Common Stock

AlphaTON Capital Corp., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors; PORT-6, a highly selective A2A receptor antagonist, which is in phase 1a for the treatment of solid tumors; PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials; and PORT-7, a potent and selective antagonist of the adenosine A2B receptor. The company was formerly known as Portage Biotech Inc. and changed its name to AlphaTON Capital Corp. in September 2025. AlphaTON Capital Corp. is based in Tortola, British Virgin Islands. more

Returns

Data is not properly formatted.

Financials

Mar '21Mar '22Mar '23Mar '24Mar '255YR TREND
Total Revenue-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Cost of Revenue--1.00K54.00K-[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":1.85,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Gross Profit--(1.00K)(54.00K)-[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":-100000,"profit":false},{"date":"2024-03-31","value":-5400000,"profit":false},{"date":"2025-03-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Operating Expenses12.44M15.59M16.58M18.20M7.42M[{"date":"2021-03-31","value":68.36,"profit":true},{"date":"2022-03-31","value":85.65,"profit":true},{"date":"2023-03-31","value":91.08,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":40.76,"profit":true}]
Operating Income(12.44M)(15.59M)(16.57M)(18.25M)(7.42M)[{"date":"2021-03-31","value":-1244000000,"profit":false},{"date":"2022-03-31","value":-1558800000,"profit":false},{"date":"2023-03-31","value":-1657500000,"profit":false},{"date":"2024-03-31","value":-1825300000,"profit":false},{"date":"2025-03-31","value":-741800000,"profit":false}]
Total Non-Operating Income/Expense-728.00K(105.74M)(67.20M)637.00K[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-14524.59,"profit":false},{"date":"2024-03-31","value":-9231.04,"profit":false},{"date":"2025-03-31","value":87.5,"profit":true}]
Pre-Tax Income(14.89M)(14.82M)(122.52M)(85.70M)(6.78M)[{"date":"2021-03-31","value":-1489200000,"profit":false},{"date":"2022-03-31","value":-1481700000,"profit":false},{"date":"2023-03-31","value":-12252200000,"profit":false},{"date":"2024-03-31","value":-8569700000,"profit":false},{"date":"2025-03-31","value":-678100000,"profit":false}]
Income Taxes2.30M4.35M(17.86M)(10.55M)-[{"date":"2021-03-31","value":52.78,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-410.29,"profit":false},{"date":"2024-03-31","value":-242.37,"profit":false},{"date":"2025-03-31","value":"-","profit":true}]
Income After Taxes-(19.17M)(104.67M)(75.15M)-[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-1916900000,"profit":false},{"date":"2023-03-31","value":-10466600000,"profit":false},{"date":"2024-03-31","value":-7514900000,"profit":false},{"date":"2025-03-31","value":"-","profit":true}]
Income From Continuous Operations-(19.17M)(104.67M)(75.38M)(6.78M)[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":-1916900000,"profit":false},{"date":"2023-03-31","value":-10466600000,"profit":false},{"date":"2024-03-31","value":-7538200000,"profit":false},{"date":"2025-03-31","value":-677800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income(15.83M)(16.87M)(104.61M)(75.34M)(6.77M)[{"date":"2021-03-31","value":-1583300000,"profit":false},{"date":"2022-03-31","value":-1687000000,"profit":false},{"date":"2023-03-31","value":-10461100000,"profit":false},{"date":"2024-03-31","value":-7533900000,"profit":false},{"date":"2025-03-31","value":-676700000,"profit":false}]
EPS (Diluted)-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ATON
Cash Ratio 2.02
Current Ratio 3.08

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ATON
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ATON
Debt Ratio Lower is generally better. Negative is bad. 0.74
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.52

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ATON
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is AlphaTON Capital Corp. share price today?

AlphaTON Capital Corp. (ATON) share price today is $5.39

Can Indians buy AlphaTON Capital Corp. shares?

Yes, Indians can buy shares of AlphaTON Capital Corp. (ATON) on Vested. To buy AlphaTON Capital Corp. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ATON stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AlphaTON Capital Corp. be purchased?

Yes, you can purchase fractional shares of AlphaTON Capital Corp. (ATON) via the Vested app. You can start investing in AlphaTON Capital Corp. (ATON) with a minimum investment of $1.

How to invest in AlphaTON Capital Corp. shares from India?

You can invest in shares of AlphaTON Capital Corp. (ATON) via Vested in three simple steps:

  • Click on Sign Up or Invest in ATON stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in AlphaTON Capital Corp. shares
What is AlphaTON Capital Corp. 52-week high and low stock price?

The 52-week high price of AlphaTON Capital Corp. (ATON) is $15.82. The 52-week low price of AlphaTON Capital Corp. (ATON) is $2.95.

What is AlphaTON Capital Corp. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AlphaTON Capital Corp. (ATON) is 0.00

What is the Market Cap of AlphaTON Capital Corp.?

The market capitalization of AlphaTON Capital Corp. (ATON) is $33.32M

What is AlphaTON Capital Corp.’s stock symbol?

The stock symbol (or ticker) of AlphaTON Capital Corp. is ATON

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top